ClinConnect ClinConnect Logo
Search / Trial NCT00803660

Survey on the Treatment of Hypertension in Patients With Type 2 Diabetes

Launched by ASTRAZENECA · Dec 4, 2008

Trial Information

Current as of July 21, 2025

Completed

Keywords

Hypertension Bp Diabetes Anti Hypertensive Treatment Ace I Arb

ClinConnect Summary

No description provided

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Provision of written informed consent
  • Patient was diagnosed with type 2 diabetes
  • Patient is on antihypertensive treatments for at least 3 months, with the same regimen for a minimum of 4 weeks prior to survey
  • Exclusion Criteria:
  • Patients are critically ill, had mental health problems or difficulty in communication
  • Patients who are unwilling or unable to provide informed consent
  • Involvement in the planning and conduct of the study (applies to both AstraZeneca staff or staff at the study site).

About Astrazeneca

AstraZeneca is a global biopharmaceutical company dedicated to the discovery, development, and commercialization of innovative medicines across various therapeutic areas, including oncology, cardiovascular, respiratory, and autoimmune diseases. With a strong commitment to scientific research and patient-centric solutions, AstraZeneca leverages cutting-edge technology and a robust pipeline to address unmet medical needs. The company collaborates with healthcare professionals, academic institutions, and other organizations to advance clinical trials and deliver transformative therapies, aiming to improve health outcomes and enhance the quality of life for patients worldwide.

Locations

Ho Chi Minh, , Vietnam

Hanoi, , Vietnam

Qui Nhon, Binh Dinh, Vietnam

Bien Hoa, Dong Nai, Vietnam

Thong Nhat, Dong Nai, Vietnam

Nha Trang, Khanh Hoa, Vietnam

Ca Mau, , Vietnam

Can Tho, , Vietnam

Nam Dinh, , Vietnam

Thai Binh, , Vietnam

Buon Me Thuoc, Dak Lak, Vietnam

Hue, Thua Thien, Vietnam

An Giang, , Vietnam

Bac Lieu, , Vietnam

Da Nang, , Vietnam

Dong Thap, , Vietnam

Hai Phong, , Vietnam

Kien Giang, , Vietnam

Tien Giang, , Vietnam

Patients applied

0 patients applied

Trial Officials

Dang Van Phuoc, PhD.

Principal Investigator

University of Medicine and Pharmacy of HCMC

Pham Nguyen Vinh, PhD.

Principal Investigator

Tam Duc Heart Hospital

Pham Gia Khai, PhD.

Principal Investigator

Vietnam Heart Association

Nguyen Thy Khue, PhD

Principal Investigator

Endocrinology and Diabetes Association of HCMC

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials